To support the reconstruction of the disease control system and comprehensively enhance epidemic prevention and control capabilities, following the earlier collaboration with Huashan Hospital on the Single-Tube 17-plex Respiratory Pathogen Detection, Turtle Technology is set to launch the '13+X' Ultra-Multiplex Respiratory Pathogen Disease Control Special Solution. The '13' represents the 13 respiratory pathogens foundamentally required by the disease control authority, and 'X' encompasses seasonal, regional, and forward-looking respiratory pathogen types potentially exceeding 10. This solution simultaneously addresses the foundational, comprehensive, flexible, and forward-looking needs of disease control.
The '13+X' solution relies on Turtle Technology's innovative Exponential Ultra-Multiplex Digital PCR Technology. Compared to traditional multiplex fluorescent PCR, this technology offers the following significant advantages:
Welcome to collaborate with Turtle Technology in advancing the '13+X' Disease Control Special Solution and the extensive application of exponential super-multiplex digital PCR technology in the fields of disease control, molecular diagnostics, and life sciences.
About Turtle Technology
Turtle Technology is committed to leading the life sciences and molecular diagnostics into the digital era. Having been approved as the National Demonstration Center for Genetic Testing Technology and obtaining the first Digital PCR Metrological Evaluation Certificate, we have introduced a variety of digital PCR systems. This marks a comprehensive technological innovation across the entire industrial chain, including genetic testing instruments, chip consumables, Ultra-Multiplex technology, and ultra-high specificity polymerase.
